Value of Porous Titanium Alloy Plates for Chest Wall Reconstruction after Resection of Chest Wall Tumors

  • Qi, Yu (Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University) ;
  • Li, Xin (Department of Oncology, The First Affiliated Hospital of Zhengzhou University) ;
  • Zhao, Song (Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University) ;
  • Han, Yong (State Key Laboratory for Mechanical Behavior of Materials, Xi'an Jiaotong University)
  • Published : 2014.06.15


Objective: To explore the value of porous titanium alloy plates for chest wall reconstruction after resection of chest wall tumors. Materials and Methods: A total of 8 patients with chest wall tumors admitted in our hospital from Jan. 2006 to Jan. 2009 were selected and underwent tumor resection, then chest wall repair and reconstruction with porous titanium alloy plates for massive chest wall defects. Results: All patients completed surgery successfully with tumor resection-induced chest wall defects being $6.5{\times}7cm{\sim}12{\times}15.5$ cm in size. Two weeks after chest wall reconstruction, only 1 patient had subcutaneous fluidify which healed itself after pressure bandaging following fluid drainage. Postoperative pathological reports showed 2 patients with costicartilage tumors, 1 with squamous cell carcinoma of lung, 1 with lung adeno-carcinoma, 1 with malignant lymphoma of chest wall, 2 with chest wall metastasis of breast cancers and 1 with chest wall neurofibrosarcoma. All patients had more than 2~5 years of follow-up, during which time 1 patient with breast cancer had surgical treatment due to local recurrence after 7 months and none had chest wall reconstruction associated complications. The mean survival time of patients with malignant tumors was ($37.3{\pm}5.67$) months. Conclusions: Porous titanium alloy plates are safe and effective in the chest wall reconstruction after resection of chest tumors.


  1. Afsharfard A, Mozaffar M, Orang E, et al (2013). Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev, 14, 6905-11
  2. Alipour S, Omranipour R, Jahanzad I, et al (2013). Very young breast cancer in a referral center in Tehran, Iran; review of 55 cases aged 25 or less throughout 33 years. Asian Pac J Cancer Prev, 14, 6529-32.
  3. Alipour S, Hadji M, Hosseini L, et al (2014). Levels of serum 25-hydroxy-vitamin D in benign and malignant breast masses.Asian Pac J Cancer Prev, 15, 129-32.
  4. Aranda JL, Varela G, Benito P, et al (2008). Donor cryopreserved rib allografts for chest wall reconstruction. Interact Cardiovasc Thorac Surg, 7, 858-60.
  5. Berthet JP, Canaud L, D'Annoville T, et al (2011). Titanium plates and Dualmesh: a modern combination for reconstructing very large chest wall defects. Ann Thor Surg, 91, 1709-16.
  6. Fouladi N, Ali-Mohammadi H, Pourfarzi F, et al (2014). Exploratory study of factors affecting continuity of cancer care: Iranian Women's perceptions. Asian Pac J Cancer Prev, 15, 133-7.
  7. Berthet JP, D'Annoville T, Canaud L, et al (2011). Use of the titanium vertical ribs osteosynthesis system for reconstruction of large posterolateral chest wall defect in lung cancer. Interact Cardiovasc Thorac Surg, 13, 223-5.
  8. Berthet JP, Solovei L, Tiffet O, et al (2013). Chest-wall reconstruction in case of infection of the operative site: is there any interest in titanium rib osteosynthesis? Eur J Cardiothorac Surg, 44, 866-74.
  9. Errani C, Ruggieri P, Asenzio MAN, et al (2010). Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev, 36, 1-7.
  10. Fujii T, Yajima R, Morita H, et al (2014). A Rare Case of Anterior Chest Wall Schwannoma Masquerading as a Breast Tumor. Int Surg, 99, 196-9.
  11. Guo L, Xing X, Li J, et al (2011). Reconstruction of full-thickness chest wall defects. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 25, 1465-8.
  12. Hu Q, Luo Z, Xu T, et al (2014). FOXA1: a promising prognostic marker in breast cancer. Asian Pac J Cancer Prev, 15, 11-6.
  13. Hu Q, Chen WX, Zhong SL, et al (2013). Current progress in the treatment of metaplastic breast carcinoma. Asian Pac J Cancer Prev, 14, 6221-5.
  14. Huemer GM, Puelzl P, Schoeller T (2012). Breast and chest wall reconstruction with the transverse musculocutaneous gracilis flap in poland syndrome. Plast Reconstr Surg, 130, 779-83.
  15. Jia WJ, Jia HX, Feng HY, et al (2014). HER2-enriched tumors have the highest risk of local recurrence in Chinese patients treated with breast conservation therapy. Asian Pac J Cancer Prev, 15, 315-20.
  16. Miller DL, Force SD, Pickens A, et al (2013). Chest wall reconstruction using biomaterials. Ann Thorac Surg, 95, 1050-6.
  17. Kronowitz SJ, Robb GL (2009). Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg, 124, 395-408.
  18. Maeda S, Yamada T, Watanabe T, et al (2014). Contribution of surgical margin for surgical outcome of the chest wall tumors. Kyobu Geka, 67, 15-20.
  19. Matsumoto K, Sano I, Nakamura A, et al (2012). Anterior chest wall reconstruction with titanium plate sandwiched between two polypropylene sheets. Gen Thorac Cardiovasc Surg, 60, 590-2.
  20. Mirzabeigi MN, Moore JH Jr, Tuma GA (2011). The use of permacol for chest wall reconstruction in a case of desmoids tumour resection. J Plast Reconstr Aesthet Surg, 64, 406-8.
  21. Munhoz AM, Montag E, Arruda E, et al (2011). Immediate locally advanced breast cancer and chest wall reconstruction: surgical planning and reconstruction strategies with extended VY latissimus dorsi myocutaneous flap. Plast Reconstr Surg, 127, 2186-97.
  22. Nam SJ, Kim S, Lim BJ, et al (2011). Imaging of primary chest wall tumors with radiologic-pathologic correlation. Radiographics, 31, 749-70.
  23. Nemeth NL, Butler CE (2009). Complex torso reconstruction with human acellular dermal matrix: long-term clinical follow-up. Plast Reconstr Surg, 123, 192-6.
  24. Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, et al (2011). Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer, 104, 37-42.
  25. Noda M, Endo C, Hosaka T, et al (2011). Dedifferentiated chondrosarcoma of the chest wall: reconstruction with polypropylene meshusing a transverse rectus abdominis myocutaneous flap. Gen Thorac Cardiovasc Surg, 59, 199-201.
  26. Shang XF, Wang ZJ, Han DX, et al (2011). Research on defects of titanium alloy laser rapid forming. Adv Mat Res, 189, 3726-30.
  27. Ozkan-Gurdal S, Cabioglu N, Ozcinar B, et al (2014). Factors predicting microinvasion in Ductal Carcinoma in situ. Asian Pac J Cancer Prev, 15, 55-60.
  28. Rocco G, Mori S, Fazioli F, et al (2012). The use of biomaterials for chest wall reconstruction 30 years after radical surgery and radiation. Ann Thorac Surg, 94, e109-e10.
  29. Sedighi A, Hamed EA, Mohammadian K, et al (2013). Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran.Asian Pac J Cancer Prev, 14, 7381-3.
  30. Talaiezadeh A, Tabesh H, Sattari A, et al (2013). Cancer incidence in southwest of iran: first report from khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev, 14, 7517-22.
  31. Thomas PA, Brouchet L (2010). Prosthetic reconstruction of the chest wall. Thorac Surg Clin, 20, 551-8.
  32. Weyant MJ, Bains MS, Venkatraman E, et al (2006). Results of chest wall resection and reconstruction with and without rigid prosthesis. Ann Thorac Surg, 81, 279-85.
  33. Yoshiya K, Koizumi T, Shinohara H, et al (2014). [Chest wall reconstruction after resection of chest wall tumors.] Kyobu Geka, 67, 31-5. [Article in Japanese]
  34. Zhang L, Wang W, Li W, et al (2011). A new alternative for bony chest wall reconstruction using biomaterial artificial rib and pleura: animal experiment and clinical application. Eur J Cardiothorac Surg, 40, 939-47.
  35. Zhu YM, Liu JW, Xu Q, et al (2013). Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.Asian Pac J Cancer Prev, 14, 5965-72.

Cited by

  1. Pinus massoniana bark extract inhibits migration of the lung cancer A549 cell line vol.13, pp.2, 2016,